|
2022-06-07 |
2022-06-06 |
V
Vente
|
Lo Steven
Chief Executive Officer
Administrateur exécutif
|
442
-3.2%
0,71
314 USD
|
442
-3.2%
|
0,71
|
314 USD
|
|
|
2022-06-07 |
2022-06-06 |
V
Vente
|
Matthews Christine
Chief Financial Officer
Dirigeant
|
82
-1.9%
0,71
58 USD
|
82
-1.9%
|
0,71
|
58 USD
|
|
|
2022-04-01 |
2022-03-31 |
V
Vente
|
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Dirigeant
|
4 006
-6.6%
0,21
842 USD
|
4 006
-6.6%
|
0,21
|
842 USD
|
|
|
2022-04-01 |
2022-03-31 |
V
Vente
|
Matthews Christine
Chief Financial Officer
Dirigeant
|
8 116
-5.3%
0,21
1 705 USD
|
8 116
-5.3%
|
0,21
|
1 705 USD
|
|
|
2022-04-01 |
2022-03-31 |
V
Vente
|
Lo Steven
Chief Executive Officer
Administrateur exécutif
|
23 633
-4.9%
0,21
4 965 USD
|
23 633
-4.9%
|
0,21
|
4 965 USD
|
|
|
2021-11-24 |
2021-11-23 |
V
Vente
|
GREATHOUSE KENNETH
Administrateur non-exécutif
|
10 000
-18.7%
0,60
6 018 USD
|
10 000
-18.7%
|
0,60
|
6 018 USD
|
|
|
2021-06-07 |
2021-06-04 |
V
Vente
|
Lewis Hayley
See Remarks
Dirigeant
|
1 709
-3.3%
0,81
1 376 USD
|
1 709
-3.3%
|
0,81
|
1 376 USD
|
|
|
2021-06-07 |
2021-06-04 |
V
Vente
|
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Dirigeant
|
1 709
-3.3%
0,81
1 376 USD
|
1 709
-3.3%
|
0,81
|
1 376 USD
|
|
|
2021-06-07 |
2021-06-04 |
V
Vente
|
Matthews Christine
Chief Financial Officer
Dirigeant
|
1 709
-1.7%
0,81
1 376 USD
|
1 709
-1.7%
|
0,81
|
1 376 USD
|
|
|
2019-04-18 |
2019-04-11 |
A
Achat
|
WALKER JOHN PETER
President & CEO
Administrateur exécutif
|
100 000
+55.5%
3,50
350 000 USD
|
100 000
+55.5%
|
3,50
|
350 000 USD
|
|
|
2018-02-28 |
2018-02-27 |
V
Vente
|
Amzak Capital Management, LLC
Actionnaire important
|
5 901
-100.0%
8,26
48 760 USD
|
5 901
-100.0%
|
8,26
|
48 760 USD
|
|
|
2018-02-28 |
2018-02-27 |
V
Vente
|
Amzak Capital Management, LLC
Actionnaire important
|
80 880
-31.6%
8,36
675 914 USD
|
80 880
-31.6%
|
8,36
|
675 914 USD
|
|
|
2018-02-28 |
2018-02-26 |
V
Vente
|
Amzak Capital Management, LLC
Actionnaire important
|
1 500
-0.6%
11,00
16 500 USD
|
1 500
-0.6%
|
11,00
|
16 500 USD
|
|
|
2017-12-08 |
2017-12-06 |
A
Achat
|
GREATHOUSE KENNETH
|
55 000
+37.9%
0,61
33 407 USD
|
55 000
+37.9%
|
0,61
|
33 407 USD
|
|
|
2017-12-04 |
2017-12-01 |
A
Achat
|
GREATHOUSE KENNETH
|
50 000
+52.6%
0,62
31 080 USD
|
50 000
+52.6%
|
0,62
|
31 080 USD
|
|
|
2017-12-04 |
2017-11-30 |
A
Achat
|
GREATHOUSE KENNETH
|
45 000
+90.0%
0,62
27 927 USD
|
45 000
+90.0%
|
0,62
|
27 927 USD
|
|
|
2017-11-16 |
2017-11-15 |
A
Achat
|
GREATHOUSE KENNETH
|
15 000
+42.9%
0,58
8 675 USD
|
15 000
+42.9%
|
0,58
|
8 675 USD
|
|
|
2017-11-16 |
2017-11-14 |
A
Achat
|
GREATHOUSE KENNETH
|
35 000
+inf%
0,64
22 484 USD
|
35 000
+inf%
|
0,64
|
22 484 USD
|
|
|
2017-05-25 |
2017-05-25 |
A
Achat
|
Erbez Georgia
CFO and Chief Business Officer
Dirigeant
|
68 000
+142.4%
1,32
89 760 USD
|
68 000
+142.4%
|
1,32
|
89 760 USD
|
|
|
2017-05-25 |
2017-05-25 |
A
Achat
|
WALKER JOHN PETER
Interim CEO
Administrateur exécutif
|
37 550
+22.2%
1,37
51 338 USD
|
37 550
+22.2%
|
1,37
|
51 338 USD
|
|
|
2017-05-25 |
2017-05-24 |
A
Achat
|
WALKER JOHN PETER
Interim CEO
Administrateur exécutif
|
36 166
+27.2%
1,34
48 553 USD
|
36 166
+27.2%
|
1,34
|
48 553 USD
|
|
|
2017-02-14 |
2017-02-13 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
1 099 996
-53.6%
2,01
2 211 432 USD
|
1 099 996
-53.6%
|
2,01
|
2 211 432 USD
|
|
|
2017-02-14 |
2017-02-13 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
1 099 996
-53.6%
2,01
2 211 432 USD
|
1 099 996
-53.6%
|
2,01
|
2 211 432 USD
|
|
|
2016-09-20 |
2016-09-16 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
7 471
-0.4%
0,75
5 603 USD
|
7 471
-0.4%
|
0,75
|
5 603 USD
|
|
|
2016-09-20 |
2016-09-16 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
7 471
-0.4%
0,75
5 603 USD
|
7 471
-0.4%
|
0,75
|
5 603 USD
|
|
|
2016-09-15 |
2016-09-13 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
10 000
-0.5%
0,74
7 400 USD
|
10 000
-0.5%
|
0,74
|
7 400 USD
|
|
|
2016-09-15 |
2016-09-13 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
10 000
-0.5%
0,74
7 400 USD
|
10 000
-0.5%
|
0,74
|
7 400 USD
|
|
|
2016-08-31 |
2016-08-29 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
50 000
-2.4%
1,01
50 440 USD
|
50 000
-2.4%
|
1,01
|
50 440 USD
|
|
|
2016-08-31 |
2016-08-29 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
50 000
-2.4%
1,01
50 440 USD
|
50 000
-2.4%
|
1,01
|
50 440 USD
|
|
|
2016-08-26 |
2016-08-24 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
1 200
-0.1%
1,21
1 452 USD
|
1 200
-0.1%
|
1,21
|
1 452 USD
|
|
|
2016-08-26 |
2016-08-24 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
1 200
-0.1%
1,21
1 452 USD
|
1 200
-0.1%
|
1,21
|
1 452 USD
|
|
|
2016-08-22 |
2016-08-19 |
A
Achat
|
Erbez Georgia
Interim CFO
Dirigeant
|
47 750
+inf%
1,32
63 030 USD
|
47 750
+inf%
|
1,32
|
63 030 USD
|
|
|
2016-08-22 |
2016-08-19 |
A
Achat
|
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Dirigeant
|
15 920
+inf%
1,32
21 014 USD
|
15 920
+inf%
|
1,32
|
21 014 USD
|
|
|
2016-08-22 |
2016-08-19 |
A
Achat
|
Lewis Hayley
VP, Reg Affairs & Quality
Dirigeant
|
4 775
+inf%
1,32
6 303 USD
|
4 775
+inf%
|
1,32
|
6 303 USD
|
|
|
2016-08-22 |
2016-08-19 |
A
Achat
|
WALKER JOHN PETER
Administrateur non-exécutif
|
63 700
+inf%
1,32
84 084 USD
|
63 700
+inf%
|
1,32
|
84 084 USD
|
|
|
2016-08-22 |
2016-08-19 |
A
Achat
|
Alataris Konstantinos
President, CEO
Administrateur exécutif
|
127 389
+inf%
1,32
168 153 USD
|
127 389
+inf%
|
1,32
|
168 153 USD
|
|
|
2016-08-22 |
2016-08-19 |
A
Achat
|
XANTHOPOULOS KLEANTHIS G
Administrateur non-exécutif
|
15 920
+265.3%
1,32
21 014 USD
|
15 920
+265.3%
|
1,32
|
21 014 USD
|
|
|
2016-07-21 |
2016-07-21 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
8 989
-0.4%
1,33
11 957 USD
|
8 989
-0.4%
|
1,33
|
11 957 USD
|
|
|
2016-07-21 |
2016-07-21 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
8 989
-0.4%
1,33
11 957 USD
|
8 989
-0.4%
|
1,33
|
11 957 USD
|
|
|
2016-07-21 |
2016-07-20 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
14 158
-0.7%
1,24
17 550 USD
|
14 158
-0.7%
|
1,24
|
17 550 USD
|
|
|
2016-07-21 |
2016-07-20 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
14 158
-0.7%
1,24
17 550 USD
|
14 158
-0.7%
|
1,24
|
17 550 USD
|
|
|
2016-07-21 |
2016-07-19 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
534
-0.0%
1,17
625 USD
|
534
-0.0%
|
1,17
|
625 USD
|
|
|
2016-07-21 |
2016-07-19 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
534
-0.0%
1,17
625 USD
|
534
-0.0%
|
1,17
|
625 USD
|
|
|
2016-07-15 |
2016-07-13 |
V
Vente
|
BARRETT M JAMES
Actionnaire important
|
13 382
-0.6%
1,20
16 060 USD
|
13 382
-0.6%
|
1,20
|
16 060 USD
|
|
|
2016-07-15 |
2016-07-13 |
V
Vente
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
13 382
-0.6%
1,20
16 060 USD
|
13 382
-0.6%
|
1,20
|
16 060 USD
|
|
|
2015-02-02 |
2015-01-30 |
A
Achat
|
BARRETT M JAMES
Administrateur non-exécutif
Actionnaire important
|
23 457
+1.1%
11,00
258 027 USD
|
23 457
+1.1%
|
11,00
|
258 027 USD
|
|
|
2015-02-02 |
2015-01-30 |
A
Achat
|
New Enterprise Associates 12, Limited Partnership
Actionnaire important
|
23 457
+1.1%
11,00
258 027 USD
|
23 457
+1.1%
|
11,00
|
258 027 USD
|
|
|
2015-02-02 |
2015-01-30 |
A
Achat
|
BioMed Realty Trust Inc
Actionnaire important
|
26 543
+5.1%
11,00
291 973 USD
|
26 543
+5.1%
|
11,00
|
291 973 USD
|
|
